Sera Prognostics (SERA) EBITDA Yield: History & Chart

Sera Prognostics, Inc.(SERA)

Medical - Diagnostics & Research · Salt Lake City, UT

$2.03+0.03 (+1.50%)

Delayed quote: Oct 6, 2026, 1:09 PM EDT

About Sera Prognostics, Inc.

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.

Salt Lake City, UT

72 employees

www.sera.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Zhenya Lindgardt

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Sera Prognostics, Inc. (SERA)	$77.53M	N/A	N/A	N/A	N/A
Neonc Technologies Holdings, Inc. (NTHI)vs ›	$77.21M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$78.35M	N/A	N/A	N/A	N/A
Hyperfine, Inc. (HYPR)vs ›	$76.64M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.76M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$76.14M	9.69%	5.52%	5.52%	5.52%
Outset Medical, Inc. (OM)vs ›	$75.63M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$80.59M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$79.96M	N/A	N/A	N/A	N/A
Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs ›	$82.53M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Sera Prognostics, Inc. (SERA)

$77.53M

N/A

Neonc Technologies Holdings, Inc. (NTHI)vs ›

$77.21M

N/A

Pulmonx Corporation (LUNG)vs ›

$78.35M

N/A

Hyperfine, Inc. (HYPR)vs ›

$76.64M

N/A

Inovio Pharmaceuticals, Inc. (INO)vs ›

$78.76M

N/A

SkinHealth Systems Inc. (SKIN)vs ›

$76.14M

9.69%

5.52%

Outset Medical, Inc. (OM)vs ›

$75.63M

N/A

Nutriband Inc. (NTRB)vs ›

$80.59M

N/A

Citius Oncology, Inc. (CTOR)vs ›

$79.96M

N/A

Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs ›

$82.53M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

SERA EBITDA Yield Metrics

SERA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics